Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Total 13F shares
-
62,518,041
-
Share change
-
+10,254,165
-
Total reported value
-
$2,042,133,962
-
Put/Call ratio
-
23%
-
Price per share
-
$32.66
-
Number of holders
-
184
-
Value change
-
+$338,978,921
-
Number of buys
-
108
-
Number of sells
-
66
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q4 2020
As of 31 Dec 2020,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
184 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,518,041 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., Avoro Capital Advisors LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, Foresite Capital Management IV, LLC, EcoR1 Capital, LLC, RTW INVESTMENTS, LP, and Holocene Advisors, LP.
This page lists
185
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.